Shire gets rights to Renovo's scar treatment Juvista; terminated
Renovo Group PLC (therapeutics for scar prevention and wound healing) licensed Shire PLC exclusive rights to market its scar reducer Juvista worldwide, except in the EU states where Renovo keeps the product.
- Specialty Pharmaceuticals
- Large Molecule
- Includes Equity
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com